LLY compared with PDSB: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

PDSBPDS Biotechnology Corp

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

PDSBPDS Biotechnology Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,407.25▼−0.27%· post 1,416.42

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

PDSBPDS Biotechnology Corp

1.40▲+1.92%· post 1.43

ClosedNov 3 '26

Mkt cap$76.7MRevenue—Revenue—

Compare

ClosedNov 3 '26

LLYELI Lilly & Co

PDSBPDS Biotechnology Corp

1,407.25▼−0.27%post 1,416.42

Price

1.40▲+1.92%post 1.43

$1.3T

Mkt cap

$76.7M

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,407.25▼−0.27%vsPDSB1.40▲+1.92%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PDSB: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only PDSB 2

MRKMerckcustomer

—NCIunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

LLY, solidPDSB, dashed